Pregnant women with HIV can be reassured that protease inhibitors are safer than previously thought in terms of risk to the foetus, according to research from the National Perinatal Epidemiology Unit ...

In a recent study posted to the bioRxiv* pre-print server, a team of researchers discovered S-217622, a non-covalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease ...

In a recent study posted to the Research Square preprint* server, a team of researchers investigated the toxicity and absorption, distribution, metabolism, and excretion (ADME) characteristics of a ...

Gilead Sciences Inc. recently disclosed details on the work that led to the discovery of elunonavir (GS-1156), an unboosted HIV protease inhibitor currently in phase I studies.

As of today, the central role of mitochondrial metabolism associated with tumorigenesis and progression of malignancies has been deeply investigated. Moreover, oxidative phosphorylation inhibition ...

As of today, the central role of mitochondrial metabolism associated with tumorigenesis and progression of malignancies has been deeply investigated. Moreover, oxidative phosphorylation inhibition ...

As humans domesticated plants, they saved certain seeds to plant in the next growing season based on desirable traits. Susceptibility to diseases popped up on this path to domestication, but wild ...

A higher maternal HIV load in pregnancy is linked toward earlier onset of puberty in HIV-exposed and uninfected boys but not girls.

Your doctors have lots of choices when it comes to which drug combination or regimen you should take for your HIV. They can help you think through your options. Many of the medicines you’ll take help ...

On Thursday, the FDA approved lenacapavir, to be sold as Yeztugo, for the prevention of HIV in the U.S. The below essay, adapted from “Breakthrough: The Quest for Life-Changing Medicine” by William ...